Free Trial

Teacher Retirement System of Texas Buys Shares of 42,788 UiPath Inc. (NYSE:PATH)

UiPath logo with Business Services background
Remove Ads

Teacher Retirement System of Texas acquired a new stake in shares of UiPath Inc. (NYSE:PATH - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 42,788 shares of the company's stock, valued at approximately $544,000.

Several other large investors also recently modified their holdings of PATH. Smartleaf Asset Management LLC lifted its position in shares of UiPath by 88.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,454 shares of the company's stock worth $31,000 after buying an additional 1,152 shares during the period. First Horizon Advisors Inc. raised its stake in UiPath by 47.8% during the fourth quarter. First Horizon Advisors Inc. now owns 2,487 shares of the company's stock worth $32,000 after acquiring an additional 804 shares in the last quarter. EverSource Wealth Advisors LLC lifted its holdings in shares of UiPath by 141.4% during the fourth quarter. EverSource Wealth Advisors LLC now owns 2,974 shares of the company's stock valued at $38,000 after acquiring an additional 1,742 shares during the period. V Square Quantitative Management LLC boosted its stake in shares of UiPath by 33.4% in the 4th quarter. V Square Quantitative Management LLC now owns 3,030 shares of the company's stock valued at $39,000 after purchasing an additional 759 shares in the last quarter. Finally, Quarry LP grew its holdings in shares of UiPath by 654.4% in the 3rd quarter. Quarry LP now owns 3,146 shares of the company's stock worth $40,000 after purchasing an additional 2,729 shares during the last quarter. 62.50% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on PATH. Royal Bank of Canada reissued a "sector perform" rating and set a $13.00 price target on shares of UiPath in a report on Wednesday, March 26th. Morgan Stanley cut their target price on shares of UiPath from $16.00 to $12.00 and set an "equal weight" rating for the company in a research note on Thursday, March 13th. Wells Fargo & Company decreased their price target on UiPath from $13.00 to $11.00 and set an "equal weight" rating on the stock in a research report on Thursday, March 13th. JPMorgan Chase & Co. raised their price target on UiPath from $17.00 to $18.00 and gave the company an "overweight" rating in a report on Friday, December 6th. Finally, Canaccord Genuity Group reduced their price objective on UiPath from $19.00 to $14.00 and set a "buy" rating on the stock in a research note on Thursday, March 13th. Two analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and an average target price of $13.62.

Remove Ads

Read Our Latest Report on PATH

Insider Buying and Selling at UiPath

In other UiPath news, CAO Hitesh Ramani sold 25,000 shares of UiPath stock in a transaction dated Friday, January 3rd. The stock was sold at an average price of $13.05, for a total transaction of $326,250.00. Following the transaction, the chief accounting officer now directly owns 269,421 shares in the company, valued at approximately $3,515,944.05. The trade was a 8.49 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Ashim Gupta sold 47,227 shares of UiPath stock in a transaction dated Friday, January 3rd. The shares were sold at an average price of $13.06, for a total value of $616,784.62. Following the transaction, the chief financial officer now owns 856,538 shares in the company, valued at $11,186,386.28. This trade represents a 5.23 % decrease in their position. The disclosure for this sale can be found here. Insiders own 22.37% of the company's stock.

UiPath Price Performance

Shares of UiPath stock traded up $0.20 on Tuesday, hitting $10.50. 9,933,847 shares of the company's stock traded hands, compared to its average volume of 9,837,969. The firm's 50-day moving average price is $12.84 and its two-hundred day moving average price is $13.03. The stock has a market capitalization of $5.79 billion, a PE ratio of -65.64 and a beta of 1.00. UiPath Inc. has a one year low of $9.50 and a one year high of $22.83.

About UiPath

(Free Report)

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.

See Also

Institutional Ownership by Quarter for UiPath (NYSE:PATH)

Should You Invest $1,000 in UiPath Right Now?

Before you consider UiPath, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.

While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best Stocks to Own: Spring 2025 Cover

Discover the 10 best stocks to own in Spring 2025, carefully selected for their growth potential amid market volatility. This exclusive report highlights top companies poised to thrive in uncertain economic conditions—download now to gain an investing edge.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

HIMS Stock Up 120%! More Growth Ahead?

HIMS Stock Up 120%! More Growth Ahead?

Hims & Hers (NYSE: HIMS) has skyrocketed 120% in just a month! Is it the next big disruptor in healthcare, or is it overpriced?

Recent Videos

 5 Stocks to BUY NOW in April 2025
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads